L&C BIO Co.,LTD (KOSDAQ: 290650)

L&C BIO Co.,LTD Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	72,043	68,870	52,572	45,677	32,973	29,152
Other Revenue	-0	-	-0	-	-	-
Revenue	72,043	68,870	52,572	45,677	32,973	29,152
Revenue Growth (YoY)	20.64%	31.00%	15.10%	38.53%	13.11%	37.24%
Cost of Revenue	35,379	34,100	25,581	17,227	13,414	10,487
Gross Profit	36,665	34,770	26,992	28,450	19,558	18,664
Selling, General & Admin	23,187	20,941	13,941	12,057	9,555	8,023
Research & Development	4,042	3,838	2,195	2,295	2,381	1,346
Operating Expenses	29,661	27,022	17,508	15,280	12,234	9,632
Operating Income	7,004	7,748	9,484	13,170	7,324	9,032
Interest Expense	-6,191	-6,191	-3,076	-460.27	-743.24	-60.55
Interest & Investment Income	1,552	1,552	666.06	431.77	832.3	919.59
Currency Exchange Gain (Loss)	174.35	174.35	-271.63	-58.41	-0.73	3.22
Other Non Operating Income (Expenses)	4,608	171.32	231.71	302.06	16.38	55.47
EBT Excluding Unusual Items	7,147	3,454	7,034	13,385	7,429	9,950
Gain (Loss) on Sale of Investments	59,511	61,740	-2,546	3,667	5,516	-28.32
Gain (Loss) on Sale of Assets	166.43	166.43	75.75	42.98	-	-
Asset Writedown	-2,423	-2,423	-	-	-	-
Pretax Income	64,401	62,938	4,563	17,095	12,944	9,922
Income Tax Expense	14,923	14,407	-1,129	1,515	795.51	1,468
Earnings From Continuing Operations	49,478	48,531	5,692	15,580	12,149	8,454
Minority Interest in Earnings	-470.22	-170.47	-1,148	-1,766	-1,336	-1,204
Net Income	49,008	48,361	4,544	13,814	10,813	7,250
Net Income to Common	49,008	48,361	4,544	13,814	10,813	7,250
Net Income Growth	1091.26%	964.24%	-67.11%	27.76%	49.15%	39.22%
Shares Outstanding (Basic)	23	23	23	22	22	22
Shares Outstanding (Diluted)	25	25	23	22	22	22
Shares Change (YoY)	9.32%	8.98%	1.74%	1.83%	-0.33%	14.34%
EPS (Basic)	2155.15	2131.86	200.32	619.55	493.83	331.03
EPS (Diluted)	2117.79	2096.33	200.00	619.55	493.83	330.00
EPS Growth	1070.01%	948.17%	-67.72%	25.46%	49.65%	21.70%
Free Cash Flow	-39,054	-36,636	-43,607	655.69	4,403	4,473
Free Cash Flow Per Share	-1576.19	-1481.90	-1922.29	29.41	201.07	203.64
Dividend Per Share	100.000	100.000	-	-	-	-
Gross Margin	50.89%	50.49%	51.34%	62.29%	59.32%	64.02%
Operating Margin	9.72%	11.25%	18.04%	28.83%	22.21%	30.98%
Profit Margin	68.03%	70.22%	8.64%	30.24%	32.79%	24.87%
Free Cash Flow Margin	-54.21%	-53.20%	-82.95%	1.44%	13.35%	15.35%
EBITDA	12,944	13,402	13,992	16,072	8,911	10,118
EBITDA Margin	17.97%	19.46%	26.61%	35.19%	27.03%	34.71%
D&A For EBITDA	5,940	5,654	4,508	2,902	1,587	1,086
EBIT	7,004	7,748	9,484	13,170	7,324	9,032
EBIT Margin	9.72%	11.25%	18.04%	28.83%	22.21%	30.98%
Effective Tax Rate	23.17%	22.89%	-	8.86%	6.15%	14.79%
Advertising Expenses	-	1,348	723.78	363.15	192.93	264.13

Source: S&P Capital IQ. Standard template. Financial Sources.